title: OKT3 in severe early rejection: predictors for reversal in renal transplant recipients.
authors.affiliation: Department of Surgery, SUNY Health Science Center, Brooklyn 11203.
authors.forename: N
authors.initials: N
authors.lastname: Sumrani
authors.forename: V
authors.initials: V
authors.lastname: Delaney
authors.forename: D
authors.initials: D
authors.lastname: Rajpoot
authors.forename: A
authors.initials: A
authors.lastname: Tejani
authors.forename: K
authors.initials: K
authors.lastname: Butt
authors.forename: J
authors.initials: J
authors.lastname: Hong
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3; D011379:Prognosis
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D008775:Methylprednisolone